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Our previous reports demonstrated that the magnitude of natural killer (NK) cell-mediated 
cytotoxicity correlate directly with the stage and level of differentiation of tumor cells. In 
addition, we have shown previously that activated NK cells inhibit growth of cancer cells 
through induction of differentiation, resulting in the resistance of tumor cells to NK cell-medi-
ated cytotoxicity through secreted cytokines, as well as direct NK-tumor cell contact. In this 
report, we show that in comparison to IL-2 + anti-CD16mAb-treated NK cells, activation 
of NK cells by probiotic bacteria (sAJ2) in combination with IL-2 and anti-CD16mAb sub-
stantially decreases tumor growth and induces maturation, differentiation, and resistance 
of oral squamous cancer stem cells, MIA PaCa-2 stem-like/poorly differentiated pancreatic 
tumors, and healthy stem cells of apical papillae through increased secretion of IFN-γ and 
TNF-α, as well as direct NK-tumor cell contact. Tumor resistance to NK cell-mediated killing 
induced by IL-2 + anti-CD16mAb + sAJ2-treated NK cells is induced by combination of 
IFN-γ and TNF-α since antibodies to both, and not each cytokine alone, were able to restore 
tumor sensitivity to NK cells. Increased surface expression of CD54, B7H1, and MHC-I on 
NK-differentiated tumors was mediated by IFN-γ since the addition of anti-IFN-γ abolished 
their increase and restored the ability of NK cells to trigger cytokine and chemokine release; 
whereas differentiated tumors inhibited cytokine release by the NK cells. Monocytes syner-
gize with NK cells in the presence of probiotic bacteria to induce regulated differentiation of 
stem cells through secretion of IL-10 resulting in resistance to NK cell-mediated cytotoxicity 
and inhibition of cytokine release. Therefore, probiotic bacteria condition activated NK cells 
to provide augmented differentiation of cancer stem cells resulting in inhibition of tumor 
growth, and decreased inflammatory cytokine release.
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inTrODUcTiOn
Natural killer (NK) cells constitute 10–15% of human peripheral 
blood lymphocytes and are known as the first-line of defense 
against infections and neoplasia. Our recent studies indicate that 
NK cells select and differentiate both healthy and transformed 
stem-like cells, resulting in the maturation of target cells with 
which NK cells interact, and other cells in the surrounding tissues 
(1–4).
Probiotic bacteria were identified in the early twentieth century 
by Elie Metchnikoff, who found that certain strains of bacteria in 
the human gut were beneficial to homeostasis of the gut; there-
fore, these beneficial bacteria were named probiotics (5). They 
are commonly used in food and supplements to enhance innate 
immunity, such as NK cell activity, and to maintain microbial bal-
ance in the digestive tract (6–8). Majority of probiotics are lactic 
acid-producing bacteria, which includes lactobacilli, streptococci, 
and bifidobacteria. The study on probiotic bacteria is one of the 
fastest growing areas of research with promising outlook for use 
in the treatment of gut mucosal pathologies, obesity, metabolic 
syndrome, allergy, heart disease, and cancer prevention and 
treatment, to name a few (9–12). Probiotics have an effect on the 
production of immunoglobulin A (13–15), stimulation of mac-
rophage activity (16), and are likely to lessen the toxicity effect of 
anti-cancer therapy (17). They induce differentiation of immature 
dendritic cells to regulatory dendritic cells, induce regulatory T 
cells, and increase the activity of NK cells, resulting in a local 
intestinal defense (5, 7). The wide range of benefits observed with 
the use of probiotic bacteria suggests their integral role in the 
modulation of local gut immunity, as well as systemic immunity 
(14, 18, 19).
In our previous study, we demonstrated that differentiation 
of healthy and transformed stem cells directly correlate with the 
cells’ sensitivity to NK cell lysis (20). In addition, we showed that 
NK cells have a significantly influential role in promoting cell dif-
ferentiation by providing critical signals via secreted cytokines, as 
well as direct NK–stem cell interaction (2, 21–23).
Although a lot is known about the benefits and role of 
probiotic bacteria in immune modulation, the underlying 
mechanisms of such immune modulation by NK cells are not 
understood. In this paper, we provide potential mechanisms for 
the role of probiotic bacteria in regulating the function of NK 
cells in such a way that results in NK cell conditioning to sup-
port differentiation of the cells. In particular, probiotic bacteria 
induce significant split anergy in activated NK cells leading to 
decreased cytotoxicity, but significant induction of IFN-γ and 
TNF-α. Split anergy was coined previously in our laboratory 
to indicate decreased NK cell cytotoxicity in the presence of 
significant secretion of cytokines (4, 24, 25). Induction of 
split anergy in NK cells promotes differentiation of target 
cells, increases key differentiation receptors on tumor cells, 
induces tumor cell resistance to NK cell-mediated cytotoxicity, 
and inhibits inflammation due to a decrease or shut down of 
cytokine and chemokine release after tumor differentiation. In 
addition, probiotic bacteria induce significant expansion of NK 
cells (26).
MaTerials anD MeThODs
cell lines, reagents, and antibodies
RPMI 1640 supplemented with 10% fetal bovine serum (FBS) 
(Gemini Bio-Products, CA, USA) was used for the cultures of 
human NK cells and monocytes. Oral squamous carcinoma 
stem cells (OSCSCs) were isolated from oral cancer patient 
with tongue tumors at UCLA and cultured in RPMI 1640 sup-
plemented 10% FBS (Gemini Bio-Products, CA, USA), 1.4% 
antibiotic antimycotic, 1% sodium pyruvate, 1.4% non-essential 
amino acids, 1% l-glutamine, 0.2% gentamicin (Gemini Bio-
Products, CA, USA), and 0.15% sodium bicarbonate (Fisher 
Scientific, PA, USA). MIA PaCa-2 (MP2) were cultured in 
DMEM with 10% FBS and 1% penicillin and streptomycin 
(Gemini Bio-Products, CA, USA). Stem cells from the apical 
papilla (SCAPs) were cultured in DMEM complete medium 
supplemented with 2% FBS and 1% penicillin and strepto-
mycin (Gemini Bio-Products, CA, USA). Recombinant IL-2 
was obtained from NIH-BRB. Antibodies to CD16 and IL-10 
were purchased from Biolegend (San Diego, CA, USA). Anti-
MHC-I was prepared in our laboratory, and 1:100 dilution was 
found to be the optimal concentration to use. PE-conjugated 
antibodies against CD44, CD54, CD69, CD107a, and B7H1 
were obtained from Biolegend (San Diego, CA, USA). Flow 
cytometry analysis was performed using Beckman Coulter 
Epics XL cytometer (Brea, CA, USA). Antibodies to TNF-α 
and IFN-γ were prepared in our laboratory, and 1:100 dilution 
was found to be the optimal concentration to use for block-
ing experiments. Human NK and monocyte purification kits 
were obtained from Stem Cell Technologies (Vancouver, BC, 
Canada). Propidium iodide (PI) was purchased from Sigma 
Aldrich (Buffalo, NY, USA).
Purification of Peripheral Blood nK cells 
and Monocytes
PBMCs from healthy donors were isolated, and NK cells 
and monocytes were purified using isolation kits obtained 
from Stem Cell Technologies, as described before (27). The 
purity of NK cells and monocyte populations was found to 
be >90 and >95%, respectively, based on the flow cytometric 
analysis. Written informed consents approved by UCLA 
Institutional Review Board (IRB) were obtained from the 
blood donors, and all the procedures were approved by the 
UCLA IRB.
elisa and Multiplex cytokine array Kit
Single ELISA was performed as described previously (27). 
Fluorokine MAP cytokine multiplex kits were purchased from 
R&D Systems (Minneapolis, MN, USA), and the procedures 
were conducted as suggested by the manufacturer. Analysis was 
performed using the Star Station software.
surface staining and cell Death assays
Staining was performed by labeling the cells with antibodies or 
PI, as described previously (27–29).
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51cr release cytotoxicity assay
The 51Cr release assay was performed as described previously (30). 
Briefly, different numbers of purified NK cells were incubated 
with 51Cr-labeled target cells. After a 4-h incubation period, the 
supernatants were harvested from each sample and counted for 
released radioactivity using the gamma counter. The percentage 
specific cytotoxicity was calculated as follows:
 
% cytotoxicity experimental cpm spontaneous cpm
total cpm s
=
−
− pontaneous cpm  
Lytic Units (LU) 30/106 is calculated by using the inverse of the 
number of effector cells needed to lyse 30% of tumor target cells ×100.
Bacteria sonication
AJ2 is a combination of eight Gram-positive bacterial 
strains (Streptococcus thermophilus, Bifidobacterium longum, 
Bifidobacterium breve, Bifidobacterium infantis, Lactobacillus 
acidophilus, Lactobacillus plantarum, Lactobacillus casei, and 
Lactobacillus bulgaricus) used to induce differentiation of 
stem cells (4). AJ2 was re-suspended in RPMI supplemented 
with 10% FBS (Gemini Bio-Products) at a final concentra-
tion of 106/mL. The sample was sonicated for 15  s while 
on ice, then incubated for 30  s on ice, and the sonication 
process was repeated 20 times to achieve complete sonica-
tion. Lastly, the sonicated samples were aliquoted and stored 
in −80°C freezer.
stem cell Differentiation with nK cell 
supernatant
Human NK cells were purified from healthy donors’ PBMCs 
as described earlier. NK cells were left untreated or treated 
with a combination of IL-2 (1,000  U/mL) and anti-CD16mAb 
(3  μg/mL) with or without sonicated probiotic bacteria AJ2 
(sAJ2) in the presence or absence of monocytes for 18 h before 
the supernatants were removed and used in differentiation 
experiments. The amounts of IFN-γ produced by activated NK 
cells were assessed with IFN-γ ELISA (Biolegend, CA, USA). 
Differentiation of OSCSCs was conducted with gradual daily 
addition of increasing amounts of NK cell supernatant. On 
average, a total of 4,500  pg of IFN-γ containing supernatants 
obtained from IL-2 +  anti-CD16mAb +  sAJ2-treated NK cells 
was added for 4  days to induce differentiation and resistance 
of OSCSCs to NK cell-mediated cytotoxicity. However, a total 
of 2,000  pg of IFN-γ containing supernatants obtained from 
IL-2  +  anti-CD16mAb  +  sAJ2  +  monocyte-treated NK cells 
was added for 3  days to induce differentiation and resistance 
of OSCSCs to NK cell-mediated cytotoxicity. SCAPs required 
on average a total of 1,400 pg of IFN-γ containing supernatants 
obtained from IL-2 +  anti-CD16mAb +  sAJ2-treated NK cells 
during a 4-day treatment, whereas MP2 tumors required a total 
of 7,000 pg of IFN-γ containing supernatants from IL-2 + anti-
CD16mAb  +  sAJ2-treated NK cells for 4  days to promote 
differentiation and resistance to NK cell-mediated cytotoxicity. 
Afterwards, target cells were washed with 1× PBS, detached and 
used for experiments.
stem cell Differentiation with 2% 
Paraformaldehyde Fixed nK cells
Human NK cells were purified as described earlier. NK cells were 
left untreated or treated with a combination of IL-2 (1,000 U/mL) 
and anti-CD16mAb (3 μg/mL) and/or the presence of sAJ2 at 3:1 
bacteria to NK cell ratio for 18 h. Afterwards, supernatants were 
removed, and the NK cells were fixed with freshly prepared 2% 
paraformaldehyde for 15 min. NK cells were then washed three 
times with 1× PBS and added to tumor cultures. Differentiation 
of OSCSCs was conducted on average for 5 days with daily and 
gradual addition of increasing amounts of fixed NK cells. During 
the differentiation process of OSCSCs, NK cells were added to 
tumor cells at an effector to target ratio of 0.6:1 for 4 days. For 
the differentiation of MP2, an effector to target ratio of 1.5:1 was 
added to culture for 4 days. After the treatment period, NK cells 
were removed from the tumors, and the target cells were used for 
experiments.
statistical analysis
An unpaired, two-tailed Student’s t-test was performed for the 
statistical analysis. One way ANOVA with a Bonferroni post-test 
was used to compare the different groups.
resUlTs
induction of Differentiation and resistance 
of Oscscs and MP2 by supernatants  
from Probiotic Bacteria and il-2 +  
anti-cD16mab-conditioned nK cells were 
Mediated by iFn-γ and TnF-α
sAJ2 is a combination of eight strains of probiotic bacteria with 
the ability to induce synergistic production of IFN-γ when 
added to IL-2-treated or IL-2  +  anti-CD16mAb-treated NK 
cells (Table S1 in Supplementary Material). The combination 
of strains was used to provide bacterial diversity in addition to 
synergistic induction of a balanced pro- and anti-inflammatory 
cytokine and growth factor release by untreated, IL-2-treated, 
or IL-2  +  anti-CD16mAb-treated NK cells (Table S1 in 
Supplementary Material). Moreover, the quantity of each bacte-
ria within the combination of strains was titrated and adjusted 
to yield a closer ratio of IFN-γ to IL-10 to that obtained when 
NK cells are activated with IL-2 + anti-CD16mAb in the absence 
of bacteria (Table S1 in Supplementary Material). The ration-
ale behind such selection was to obtain a ratio similar to that 
obtained with NK cells activated with IL-2 +  anti-CD16mAb 
in the absence of bacteria since such treatment provided sig-
nificant differentiation of the cells (4). Interestingly, addition 
of IL-2 +  anti-CD16mAb in the presence or absence of sAJ2 
to NK cells had the highest induction of IFN-γ secretion when 
compared to untreated or IL-2 treated NK cells (Table S1 in 
Supplementary Material). No significant differences or a slight 
change in cytotoxicity could be seen either with sAJ2 or with each 
bacterial strain for untreated or IL-2-treated NK cell cytotoxicity 
(Figure S1 in Supplementary Material). Moreover, treatment of 
NK cells with IL-2 + anti-CD16mAb in the presence and absence 
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of sAJ2 inhibited cytotoxicity when compared to IL-2-treated 
NK cells, and B. longum was able to reverse the inhibition of 
cytotoxicity moderately (Figure S1 in Supplementary Material). 
The data obtained by IL-2 + anti-CD16mAb-treated NK cells in 
the presence and absence of treatment with probiotic bacteria 
suggest dissociation of cytotoxicity and cytokine secretion for 
the effect of probiotic bacteria on NK cells since they trigger 
significant IFN-γ secretion in the presence of decreased NK 
cell-mediated cytotoxicity which we had previously coined as 
split anergy (Figure S1 and Table S1 in Supplementary Material).
To determine whether supernatants obtained from 
probiotic bacteria and IL-2  +  anti-CD16mAb-treated NK 
cells are capable of inducing differentiation and resistance 
in OSCSCs or in MP2 stem-like pancreatic tumors, NK cells 
were treated as described in (Figure 1), and the supernatants 
were removed and added to tumor cells. After differentiation, 
the susceptibility of tumor cells to NK cell-mediated lysis, the 
surface expression of CD54, MHC-1, B7H1, and CD44, and 
the induction of IFN-γ and IL-8 secretion by NK cells were 
assessed (Figure  2; Figure S2 in Supplementary Material). 
Treatment of OSCSCs (Figures 2A,C) and MP2 (Figure S2A 
in Supplementary Material) with supernatants from untreated 
NK cells or NK cells treated with sAJ2 did not cause significant 
differences in the susceptibility of OSCSCs or MP2 to IL-2-
activated NK cell-mediated lysis (Figures  2A,C; Figure S2A 
in Supplementary Material). Supernatants obtained from 
IL-2 +  anti-CD16mAb-treated NK cells mediated resistance 
in OSCSCs; however, the level of resistance to IL-2 activated 
NK cells was much more prominent in OSCSCs treated with 
supernatants obtained from IL-2 +  anti-CD16mAb +  sAJ2-
treated NK cells (P < 0.05) (Figure 2A). We then studied the 
relationship between resistance of OSCSCs and MP2 to NK cell 
cytotoxicity and the modulation of key cell surface receptor 
expression on OSCSCs (Figures 2B,D) and MP2 (Figure S2B 
in Supplementary Material). Among many surface receptors 
tested, CD54, MHC-1, and B7H1 expressions on tumor cells 
were found to correlate significantly with the differentiation 
and resistance to NK cell-mediated lysis (4). NK cells treated 
with IL-2 +  anti-CD16mAb +  sAJ2 induced more differen-
tiation when compared to OSCSCs (Figure  2B) treated with 
the supernatants obtained from IL-2 +  anti-CD16mAb since 
significant increase in surface expression of CD54, MHC-1, 
and B7H1 and a moderate decrease in CD44 stem cell marker 
expression were observed on differentiated tumor cells. 
Similar results were obtained when MP2s were treated with 
supernatants from IL-2 + anti-CD16mAb + sAJ2-treated NK 
cells (Figure S2B in Supplementary Material). Supernatants 
from either untreated NK cells or NK cells treated with sAJ2 
did not have any significant effects on the surface expres-
sion of OSCSCs (Figures  2B,D) and MP2 (Figure S2B in 
Supplementary Material). Indeed, the expression of CD107a 
and CD69 on IL-2  +  anti-CD16mAb-treated NK cells was 
substantially higher in the presence of sAJ2 than in the absence 
of sAJ2 (Figure S3 in Supplementary Material).
To elucidate the mechanism by which OSCSCs and MP2 dif-
ferentiate and gain resistance to NK cell-mediated cytotoxicity, we 
determined the susceptibility of OSCSCs (Figure 2C) and MP2 
(Figure S2A in Supplementary Material) to NK cell-mediated lysis 
when the tumors were treated with supernatants from IL-2 + anti-
CD16mAb + sAJ2-treated NK cells cells with each of IFN-γ and 
TNF-α antibody alone or with the combination of the two antibod-
ies. The addition of each of anti-TNF-α and anti-IFN-γ alone to 
IL-2 + anti-CD16mAb + sAJ2 resulted in no or moderate inhibi-
tory effect on the induction of resistance of OSCSCs (Figure 2C) 
and MP2 (Figure S2A in Supplementary Material) to NK cells. 
However, the addition of both antibodies together completely 
restored the sensitivity of OSCSCs (Figure 2C) and MP2 (Figure 
S2A in Supplementary Material) to untreated and IL-2-activated 
NK cells. The addition of TNF-α antibody alone to IL-2 + anti-
CD16mAb + sAJ2-treated NK cell supernatant was able to prevent 
upregulation of CD54 surface expression on differentiated OSCSCs 
(Figure 2D) and MHC-1 on MP2, whereas the effect of anti-IFN-γ 
alone was more dominant, and it prevented the modulation of 
CD54, MHC-I, and B7H1 surface expression on both OSCSCs 
FigUre 1 | schematic representation of steps used to differentiate cancer stem-like cells with nK cell supernatants and fixed nK cells after their 
activation. Highly purified NK cells were left untreated or treated with IL-2, sAJ2, monocytes, and/or anti-CD16mAb for 18 h, after which the treated NK cells were 
centrifuged, and the supernatants were removed and used to treat target cells. For cell–cell contact studies, treated NK cells were fixed with freshly prepared 2% 
paraformaldehyde for 15 min, washed three times with 1× PBS and added to target cell cultures. After the differentiation period, NK supernatants or fixed NK cells 
were removed from target cell cultures, and the targets were used in various assays.
FigUre 2 | resistance to nK cell-mediated lysis of Oscscs treated with supernatants from il-2 + anti-cD16mab + saJ2-stimulated nK cells is 
mediated by the combination of iFn-γ and TnF-α and not each cytokine alone. Highly purified NK cells were left untreated or treated with IL-2 (1,000 U/mL) 
and anti-CD16mAb (3 μg/mL) with or without sonicated AJ2 (sAJ2) at 1:3 (NK:sAJ2) ratio for 18 h before the supernatants were harvested and added to OSCSCs 
for 4 days. Afterwards, untreated OSCSCs and those treated with different NK cell supernatants indicated in the figure were detached from the tissue culture plates, 
extensively washed with 1× PBS and labeled with 51Cr. Freshly isolated NK cells were left untreated or treated with IL-2 (1,000 U/mL) for 24 h before the cells were 
used as effector cells in 51Cr release assay against OSCSCs treated with NK supernatants. The lytic units 30/106 cells were determined using inverse number of NK 
cells required to lyse 30% of the target cells ×100. Differences between untreated OSCSCs and those cultured with IL-2 + anti-CD16mAb-treated NK or those 
stimulated with IL-2 + anti-CD16mAb + sAJ2-treated NKs were significant at a P-value of < 0.05 (*) (a). OSCSCs were differentiated as described in (a), and after 
4 days the surface expression of CD54, MHC-1, B7H1, and CD44 on untreated OSCSCs or those treated with NK cell supernatants as shown in the figure was 
assessed after staining with the PE-conjugated antibodies and analyzed using flow cytometry. Isotype control antibodies were used as controls. The numbers on the 
right hand corner are the percentages and the mean channel fluorescence intensities for each histogram (B). NK cells were treated with sAJ2 alone at 1:3 (NK:sAJ2) 
ratio or treated with IL-2 (1,000 U/mL) and anti-CD16mAb (3 μg/mL) and sAJ2 at 1:3 (NK:sAJ2) ratio in the presence of anti-TNF-α (1:100), anti-IFN-γ (1:100), or 
combination of anti-TNF-α (1:100) and anti-IFN-γ (1:100) as shown in the figure for 18 h. Afterwards, NK cell supernatants were harvested and added to OSCSCs 
for 4 days.
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FigUre 2 | continued 
Afterwards, untreated OSCSCs and those treated with NK cell supernatants were detached from the tissue culture plates, extensively washed with 1× PBS and 
labeled with 51Cr. Freshly isolated NK cells were left untreated or treated with IL-2 (1,000 U/mL) for 24 h before the cells were used as effector cells in 51Cr release 
assay against OSCSCs. The lytic units 30/106 cells were determined using inverse number of NK cells required to lyse 30% of the target cells ×100. Differences 
between untreated OSCSCs and those stimulated with IL-2 + anti-CD16mAb + sAJ2-treated NK with or without anti-TNF-α or anti-IFN-γ were significant at a 
P-value of <0.05 (*) (c). OSCSCs were treated with NK cell supernatants, as described in (c), and after 4 days the surface expression of CD54, MHC-1, and B7H1 
on untreated tumor cells or those treated with NK cell supernatants was assessed after staining with the PE-conjugated antibodies and analyzed using flow 
cytometry. Isotype control antibodies were used as controls. The numbers on the right hand corner are the percentages and the mean channel fluorescence 
intensities for each histogram (D). OSCSCs were treated with NK cell supernatants as described in (c), and the percent cell death in OSCSCs was determined 
using PI staining followed by flow cytometric analysis. The numbers on the right hand corner are the percentages of PI-positive cells for each histogram (e). Purified 
NK cells were treated with a combination of IL-2 (1,000 U/mL) and anti-CD16mAb (3 μg/mL) in the presence or absence of sAJ2 at 1:3 (NK:sAJ2) ratio with or 
without anti-TNF-α (1:100) and/or anti-IFN-γ (1:100) for 18 h. Afterwards, supernatants were removed and used for the treatment of OSCSCs. OSCSCs 
(2 × 105 cells/well) were cultured overnight before they were treated with supernatants obtained from the NK cells treated as indicated in the figure for 4 days. At the 
end of the incubation, OSCSCs were detached, and the numbers of cells were assessed using microscopy (F). Freshly isolated NK cells were treated with IL-2 
(1,000 U/mL) for 18 h. Afterwards, NK cells were added to untreated OSCSCs and those differentiated with NK cell supernatants, as described in (c), at an effector 
to target ratio of 0.5–1. After an overnight incubation, the supernatants were removed from the cocultures, and the levels of IFN-γ (g) and IL-8 (h) secretions were 
determined using specific ELISAs. Differences between untreated OSCSCs and those stimulated with IL-2 + anti-CD16mAb-treated NK or stimulated with 
IL-2 + anti-CD16mAb-treated NK + sAJ2 with or without anti-TNF-α were significant at a P-value of <0.05 (*).
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(Figure  2D) and MP2 tumors (Figure S2B in Supplementary 
Material) and blocked the moderate level of cell death induced 
by supernatants from IL-2 + anti-CD16mAb + sAJ2-treated NK 
cells in OSCSCs after differentiation (Figure  2E). Treatment of 
OSCSCs with supernatants from IL-2 + anti-CD16mAb + sAJ2-
treated NK cells in the presence of both TNF-α and IFN-γ antibod-
ies was able to inhibit modulation of surface receptor expression 
completely (Figure  2D; S2B in Supplementary Material) and 
prevented cell death (Figure 2E). In addition, OSCSCs differenti-
ated with supernatants from IL-2 + anti-CD16mAb + sAJ2 NK 
cells demonstrated inhibition of tumor growth when compared 
to either untreated OSCSCs or those treated with IL-2 +  anti-
CD16mAb in the absence of sAJ2 (Figure  2F). Treatment of 
OSCSCs with supernatants from IL-2 + anti-CD16mAb + sAJ2 
in the presence of anti-TNF-α had slight enhancing effect on 
tumor growth, whereas supernatants obtained from anti-IFN-γ 
in combination with IL-2 + anti-CD16mAb + sAJ2-treated NK 
cells enhanced tumor cell growth substantially. Supernatants from 
IL-2 + anti-CD16mAb + sAJ2-treated NK cells in combination 
with both anti-TNF-α and anti-IFN-γ when added to OSCSCs 
restored tumor cell growth to the levels which were obtained with 
untreated OSCSCs (Figure 2F).
Next, we determined whether resistance to NK cell-
mediated cytotoxicity correlates with a change in cytokine 
and chemokine secretion by NK cells in cultures with dif-
ferentiated OSCSCs (Figures 2G,H) and MP2 (Figures S4A,B 
in Supplementary Material). OSCSCs treated with IL-2 + anti-
CD16mAb-activated NK cell supernatants triggered less IFN-γ 
secretion by NK cells; however, the extent of inhibition was far 
less than OSCSCs treated with IL-2 + anti-CD16mAb + sAJ2-
treated NK cell supernatants (P  <  0.05) (Figure  2G). The 
addition of anti-IFN-γ alone, but not anti-TNF-α alone, to 
IL-2 +  anti-CD16mAb +  sAJ2 was able to restore the IFN-γ 
secretion back to the levels observed with untreated OSCSCs 
or MP2 (Figure 2G; Figure S4A in Supplementary Material). 
Supernatants from IL-2 + anti-CD16mAb-treated NK cells or 
IL-2 +  anti-CD16mAb +  sAJ2-treated NK cells when added 
to tumors inhibited IL-8 secretion in differentiated tumors 
cocultured with NK cells (P < 0.05) (Figure 2H). OSCSCs and 
MP2 differentiated with supernatants obtained from NK cells 
treated with IL-2 +  anti-CD16mAb +  sAJ2 in the presence 
of TNF-α antibody alone had little effect on the restoration 
of IL-8 secretion (Figure  2H; Figure S4B in Supplementary 
Material). In contrast, the addition of anti-IFN-γ alone, 
without anti-TNF-α, restored the IL-8 secretion in tumors 
treated with IL-2 +  anti-CD16mAb +  sAJ2 in the presence 
and absence of their cocultures with the NK cells (Figure 2H; 
Figure S4B in Supplementary Material).
The addition of supernatants Obtained 
from il-2 + anti-cD16mab +  
saJ2-Treated nK cells induced 
Differentiation and resistance of stem 
cells of apical Papilla
Similar results to those of OSCSCs and MP2 tumors were 
also obtained when non-transformed SCAPs were used to 
culture with supernatants of NK cells treated with IL-2 + anti-
CD16mAb + sAJ2 in the presence or absence of anti-IFN-γ and 
anti-TNF-α (Figure S5 in Supplementary Material). Treatment 
of SCAPs with supernatants from NK cells activated with 
IL-2 + antiCD16mAB + sAJ2 + anti-TNF-α had no or minimal 
effect on the restoration of sensitivity of SCAPs to NK cell-
mediated lysis in comparison to IL-2 + anti-CD16mAB + sAJ2 
treatment. (Figure S5A in Supplementary Material). However, 
treatment of SCAPs with supernatants from IL-2  +  anti-
CD16mAb  +  sAJ2  +  anti-IFN-γ treated NK cells was able 
to restore sensitivity of SCAPs to NK cell-mediated lysis 
moderately, and the combination of anti-TNF-α and anti-
IFN-γ when added to IL-2 +  anti-CD16mAb +  sAJ2-treated 
NK cell supernatants restored the sensitivity of SCAPs to NK 
cell-mediated lysis completely (Figure S5A in Supplementary 
Material). Sensitivity to NK cell lysis correlated with the ability 
of both anti-TNF-α and anti-IFN-γ to block upregulation of 
CD54 and MHC-1 (Figure S5B in Supplementary Material). 
Anti-IFN-γ in the absence of anti-TNF-α was able to decrease 
surface marker expression (Figure S5B in Supplementary 
Material). SCAPs differentiated with supernatants from 
IL-2 + anti-CD16mAb + sAJ2-treated NK cells demonstrated 
decreased cell growth when compared to either untreated 
SCAPs or those treated with either untreated NK supernatants 
or supernatants from IL-2  +  anti-CD16mAb-treated NK 
cells in the absence of sAJ2 (Figure S5C in Supplementary 
Material). Treatment of SCAPs with supernatants from NK 
cells treated with IL-2  +  anti-CD16mAb  +  sAJ2 and anti-
TNF-α had slight enhancing effect on cell growth, whereas 
supernatants obtained from anti-IFN-γ in combination with 
IL-2 +  anti-CD16mAb +  sAJ2-treated NK cells restored cell 
growth. Supernatants from IL-2  +  anti-CD16mAb  +  sAJ2-
treated NK cells in combination with both anti-TNF-α and 
anti-IFN-γ when added to SCAPs restored cell growth similar 
to the levels obtained with untreated SCAPs (Figure S5C in 
Supplementary Material).
resistance to nK cell-Mediated lysis 
induced by Fixed il-2 + anti-
cD16mab + saJ2-Treated nK cells Was 
Mediated by Both iFn-γ and TnF-α and 
not each cytokine alone
To determine the effects of cell–cell contact between NK cells and 
tumor cells on differentiation and resistance of tumor cells to 
NK cell-mediated cytotoxicity, we cultured purified NK cells 
untreated or treated with IL-2 + anti-CD16mAb + sAJ2 in the 
presence or absence of anti-TNF-α and anti-IFN-γ antibodies. 
Treated NK cells were then washed, fixed with 2% paraformal-
dehyde and added to OSCSCs and MP2 (Figure 1). Thereafter, 
the complete removal of fixed NK cells from tumor cell cultures 
was confirmed by microscopic assessment. Next we deter-
mined the susceptibility of OSCSCs and MP2 differentiated 
with different treatments of fixed NK cells to untreated and 
IL-2-treated NK cell lysis and the surface expression of CD54 
and MHC-1 (Figure 3; Figure S6 in Supplementary Material). 
Untreated fixed NK cells did not cause any NK cell resistance in 
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OSCSCs (Figure 3A) and MP2 (Figure S6A in Supplementary 
Material), whereas fixed IL-2 + anti-CD16mAb + sAJ2-treated 
NK cells induced resistance of OSCSCs (Figure 3A) and MP2 
(Figure S6A in Supplementary Material) to both untreated and 
IL-2-treated NK cell-mediated cytotoxicity (P  <  0.05). The 
addition of TNF-α antibody alone had no or minimal inhibi-
tory effect on the resistance of OSCSCs (Figure 3A) and MP2 
(Figure S6A in Supplementary Material). Whereas, decreases in 
OSCSCs and MP2 resistance were observed when fixed NK cells 
treated with anti-IFN-γ and IL-2 + anti-CD16mAb + sAJ2 were 
used to differentiate both tumor cell lines. The complete resto-
ration of susceptibility of OSCSCs and MP2 to untreated and 
IL-2 treated NK cells was observed when the combination of 
antibodies to IFN-γ and TNF-α and not to each cytokine alone 
was used with IL-2 + anti-CD16mAb + sAJ2 to treat NK cells 
before their fixation and addition to tumor cells to induce differ-
entiation (Figure 3A; Figure S6A in Supplementary Material). 
Resistance of OSCSCs or MP2 induced by fixed NK cells treated 
with IL-2 + anti-CD16mAb + sAJ2 correlated with the increase 
in the surface expressions of CD54 and MHC-I on OSCSCs 
(Figure 3B) and CD54, B7H1, and MHC-1 on MP2 (Figure S6B 
in Supplementary Material), and the addition of both anti-TNF-α 
and anti-IFN-γ to IL-2 +  anti-CD16mAb +  sAJ2-treated NK 
cells before their use to treat tumor cells inhibited the upregula-
tion of these receptors on tumor cells. The effect of anti-IFN-γ 
was more potent in the reduction of surface marker expression 
on tumor cells when compared to anti-TNF-α, since the addi-
tion of anti-IFN-γ significantly reduced the increase in surface 
marker expression (Figure  3B; Figure S6B in Supplementary 
Material). No or minimal cell death was observed in OSCSCs 
(Figure 3C) or MP2 (Figure S6C in Supplementary Material) 
differentiated with IL-2 + anti-CD16mAb + sAJ2-treated and 
paraformaldehyde-fixed NK cells. Treatment of MP2 with fixed 
NK cells treated with IL-2 +  anti-CD16mAb +  sAJ2 +  anti-
TNF-α had slight enhancing effect on tumor growth, whereas 
fixed NK cells obtained from anti-IFN-γ in combination with 
IL-2 + anti-CD16mAb + sAJ2-treated NK cells enhanced tumor 
cell growth substantially. NK cells treated with IL-2 +  anti-
CD16mAb + sAJ2 in combination with both anti-TNF-α and 
anti-IFN-γ when added to MP2 cells restored tumor cell growth 
to the levels obtained with untreated MP2 cells (Figure S6D in 
Supplementary Material).
Monocytes synergized with nK cells in 
the Presence of Bacteria to induce 
Differentiation of Tumors
To determine the effects of NK cells treated with or without sAJ2 
in the presence or absence of monocytes, we assessed cytotoxicity, 
secretion of IFN-γ and IL-10, and the surface expression of key 
differentiation markers on OSCSCs after their culture with super-
natants from IL-2 +  anti-CD16mAb +  sAJ2-treated NK  cells 
cocultured with autologous monocytes (Figure 4). As shown in 
Figure 4A, the highest cytotoxicity was observed when NK cells 
were treated with IL-2, and the addition of anti-CD16mAb to 
IL-2-activated NK cells induced split anergy in NK  cells. The 
addition of sAJ2 inhibited moderately the cytotoxic function of 
both IL-2-treated and IL-2 +  anti-CD16mAb-treated NK  cells 
(Figure 4A). As shown previously (2–4, 22) and in this report, 
the addition of monocytes to NK cells induced split anergy in 
NK  cells which resulted in a significant decrease in NK  cell-
mediated lysis (Figure  4A). The ability of NK cells to mediate 
cytotoxicity was drastically lost when NK cells were cultured with 
both monocytes and sAJ2 (Figure 4A).
To determine whether a drop in cytotoxicity correlated with 
substantial induction of IFN-γ from NK cells treated with or 
without IL-2 +  anti-CD16mAb in the presence of monocytes 
and sAJ2, the secretion of IFN-γ were determined at days 1, 4, 6, 
and 8 post-treatment (Figure 4B). Untreated NK cells cultured 
with monocytes produced minimal amounts of IFN-γ on the 
first day, and none was detected on the subsequent days. The 
addition of sAJ2 to NK cells cocultured with monocytes resulted 
in a significant increase in IFN-γ production by NK cells, and 
the levels remained high until day 6 but by day 8 no IFN-γ 
release was detected (Figure 4B). Without monocytes and sAJ2, 
IL-2  +  anti-CD16mAb-treated NK cells secreted moderate 
amounts of IFN-γ on day 1, and the levels dropped significantly 
on day 4 of the co-cultures (Figure  4B). On the other hand, 
IL-2 + anti-CD16mAb-treated NK cells in the presence of sAJ2 
continued to secrete high levels of IFN-γ, and the levels remained 
continuously high until day 6. IL-2 + anti-CD16mAb-treated NK 
cells cultured with monocytes also secreted high levels of IFN-γ, 
and the levels remained high until day 8 (Figure 4B). The longest 
duration in which NK cells continued to secrete IFN-γ was seen 
when NK cells were treated with IL-2 +  anti-CD16mAb with 
sAJ2 and cultured with monocytes since at day 8 considerable 
amounts of IFN-γ were still detectable from the NK cell superna-
tants (Figure 4B). No increase in cell death above that observed 
with IL-2 +  anti-CD16mAb-treated NK cells was seen when 
IL-2 + anti-CD16mAb-treated NK cells were cultured with or 
without monocytes and/or sAJ2 (Figure S7 in Supplementary 
Material). Next, we determined secretion of IL-10 in cocultures 
of NK cells with monocytes. NK cells synergized with monocytes 
to induce IL-10 secretion (Figure 4C), and the levels increased 
substantially in the presence of sAJ2 (Figure 4D).
Next, we aimed to determine if the increased and persistent 
production of IFN-γ by IL-2  +  anti-CD16mAb-treated NK 
cells cultured with monocytes and sAJ2 correlated with an 
increase in differentiation antigens on the surface of OSCSCs 
(Figures 4E,F). Supernatants obtained from untreated NK cells 
cultured with sAJ2 and monocytes induced differentiation of 
OSCSCs as observed by a slight increase in surface expression of 
B7H1, moderate upregulation of CD54 and MHC-1, and a minor 
decrease in CD44 on OSCSCs (Figure  4E). Supernatants from 
IL-2 + anti-CD16mAb-treated NK cells cultured with sAJ2 medi-
ated the next highest level of resistance in OSCSCs and induced 
on average 7-fold and 11.8-fold increase in surface expression 
of CD54 and MHC-1 on OSCSCs, respectively (Figure  4F). 
The combination of IL-2 + anti-CD16mAb +  sAJ2-treated NK 
cells cultured with monocytes was able to synergistically induce 
significant upregulation of B7H1 (12-fold), CD54 (92-fold), and 
MHC-1 (8.5-fold) (Figure 4F).
FigUre 3 | Paraformaldehyde fixed il-2 + anti-cD16 mab + saJ2-treated nK cells mediated differentiation and resistance of Oscscs against 
nK cell-mediated cytotoxicity. NK cells were left untreated or treated with a combination or IL-2 (1,000 U/mL) and anti-CD16mAb (3 μg/mL) and sAJ2 at 1:3 
(NK:sAJ2) ratio in the presence of anti-TNF-α (1:100), anti-IFN-γ (1:100), or combination of anti-TNF-α (1:100) and anti-IFN-γ (1:100) for 18 h. Afterwards, 
supernatants were removed, and the NK cells were fixed with freshly prepared 2% paraformaldehyde for 15 min. NK cells were then washed three times with 1× 
PBS and added to tumor cultures. Differentiation of OSCSCs was conducted for 5 days with daily and gradual addition of increasing amounts of fixed NK cells. The 
complete removal of fixed NK cells from tumor cell cultures prior to the cytotoxicity assays was determined by microscopic assessment. Freshly isolated NK cells 
were left untreated or treated with IL-2 (1,000 U/mL) for 18 h before the cells were used as effector cells in 51Cr release assay against tumor cells cultured with the 
NK cells. The lytic units 30/106 cells were determined using inverse number of NK cells required to lyse 30% of the target cells ×100. Differences between 
untreated OSCSCs and those stimulated with fixed IL-2 + anti-CD16mAb-treated NK or IL-2 + anti-CD16mAb-treated NK + sAJ2 with or without anti-TNF-α or 
anti-IFN-γ but not with the combination of anti-TNF-α and anti-IFN-γ were significant at a P-value of <0.05 (*) (a). OSCSCs were treated with fixed NK cells as 
described in (a). The surface expressions of CD54 and MHC-1 on OSCSCs were assessed after staining with the PE-conjugated antibodies and analyzed using 
flow cytometry. Isotype control antibodies were used as controls. The numbers on the right hand corner are the percentages and the mean channel fluorescence 
intensities for each histogram (B). NK cells were prepared as described in (a) and added to OSCSCs for 5 days. Afterwards, the tumor cells were washed with 1× 
PBS, and their viability was determined using PI staining followed by flow cytometric analysis (c). The numbers on the right hand corner are the percentages of 
dead cells in each histogram.
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il-10 regulation of nK cell-Mediated 
Tumor Differentiation in the Presence of 
Bacteria and Monocytes Was  
Much More Pronounced in Untreated  
nK cells Than Those Treated with il-2 and 
anti-cD16mab
Since sAJ2 induce significant IL-10 secretion in untreated 
NK cells, and the levels substantially decrease when NK cells 
are activated with IL-2 or IL-2 + anti-CD16mAb (Table S1 in 
Supplementary Material), we aimed at determining whether 
such modulation also affects tumor differentiation. To analyze 
the extent and significance of the regulatory role of IL-10 on 
untreated and activated NK cell in tumor differentiation, 
anti-IL-10mAb was added to NK cells in the presence of sAJ2 
and/or monocytes, and their supernatants were used in the 
induction of differentiation, and resistance of OSCSCs to NK 
cell mediated lysis and secretion of IFN-γ (Figures  5A,B). 
As shown in Figure  5A, the supernatants obtained from NK 
cells treated with anti-IL-10mAb + sAJ2 + monocytes induced 
resistance in OSCSCs. The increase in tumor resistance cor-
related with the upregulation of CD54, B7H1, and MHC-I on 
OSCSCs induced by supernatants from NK cells treated with 
anti-IL-10mAb + sAJ2 + monocytes which contained increased 
amounts of IFN-γ (Figures 5B,C). Supernatants obtained from 
the combination of anti-IL-10mAb with IL-2 + anti-CD16mAb-
treated NK cells in the presence or absence of monocytes and 
sAJ2 when added to OSCSCs only moderately increased cell 
surface receptors when compared to OSCSCs treated with 
supernatants from NK cells treated with IL-2 + anti-CD16mAb 
with or without monocytes and sAJ2 in the absence of anti-
IL-10mAb (Figure 5D). This correlated with downmodulation 
of IL-10 secretion when NK cells are activated with IL-2 or 
IL-2 +  anti-CD16mAb in the presence of sAJ2 (Table S1 in 
Supplementary Material). Supernatants from NK cells treated 
with IL-2 +  anti-CD16mAb-treated NK cells cocultured with 
sAJ2 and monocytes in the presence of anti-IL-10mAb when 
added to OSCSCs increased surface receptor expression mod-
erately and induced cell death of OSCSCs when compared to 
those in the absence of anti-IL-10mAb (Figures 5D,E). Thus, 
FigUre 4 | Monocytes and probiotic bacteria synergistically induce split anergy in nK cells to increase tumor cell differentiation. Purified NK cells 
were left untreated, treated with IL-2 (1000U/mL) or a combination of IL-2 (1000U/mL) and anti-CD16mAb (3μg/mL) in the presence or absence of autologous 
monocytes (1:0.2, NK cell:monocytes) and/or sAJ2 (1:0.5, NK cell:sAJ2) ratios for 18 hours before the supernatants were harvested  
(Continued)
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and added to OSCSCs. Afterwards, untreated OSCSCs and those treated with different NK cell supernatants indicated in the figure were detached from the 
tissue culture plates, extensively washed with 1X PBS and labeled with 51Cr. Freshly isolated NK cells were left untreated or treated with IL-2 (1000U/mL) for 24 
hours before the cells were used as effector cells in 51Cr release assay against OSCSCs treated with NK supernatants. The lytic units 30/106 cells were 
determined using inverse number of NK cells required to lyse 30% of the target cells X100.  NK cell cytotoxicity was determined using a standard 4 hours 51Cr 
release assay and the lytic units 30/106 were determined using inverse number of NK cells required to lyse 30% of the target cells. Differences between untreated 
NK cells and those cultured with monocytes and/or sAJ2 were significant at a P-value of < 0.05 (*) (a). NK cells were prepared as described in (a). After days 1, 
4, 6, and 8, the supernatants were removed from the cocultures, and the levels of IFN-γ secretions were determined using specific ELISAs. Differences between 
untreated NK cells and those stimulated with IL-2 + anti-CD16mAb-treated NK cells or treated with IL-2 + anti-CD16mAb-treated NK cells + monocytes with or 
without sAJ2 were significant at a P-value of <0.05 (*) (B). Purified NK cells were left untreated or treated with a combination of IL-2 (1,000 U/mL) and anti-
CD16mAb (3 μg/mL) in the presence or absence of monocytes (1:0.2, NK cell:monocytes) for 18 h. Afterwards, the supernatants were removed, and the levels of 
IL-10 were determined using specific ELISAs. Differences between IL-2 + anti-CD16mAb-treated NK cells and IL-2 + anti-CD16mAb-treated NK cells cultured 
with monocytes were significant at a P-value of <0.05 (*) (c). NK cells were prepared as described in (a). After 36 h, the supernatants were removed from the 
cocultures, and the levels of IL-10 secretions were determined using specific ELISAs. Differences between unstimulated NK cells and those stimulated with sAJ2 
and/or monocytes were significant at a P-value of <0.05 (*) (D). Purified untreated NK cells were cultured in the presence and absence of untreated monocytes 
with and without sAJ2 for 18 hours. Then the supernatants were added to OSCSCs for 4 days. Afterwards, OSCSCs were removed and the surface expressions 
of B7H1, CD54, MHC-1, and CD44 on untreated OSCSCs and those treated with NK cells were assessed after staining with the PE conjugated antibodies and 
analyzed using flow cytometry (e). NK cells were left untreated or treated with IL-2 (1,000 U/mL) and anti-CD16mAb (3 μg/mL) in the presence of monocytes 
(1:0.5, NK cell:monocytes) and/or sAJ2 (1:0.5, NK:sAJ2) for 18 h, and then the supernatants were removed and added to OSCSCs for 4 days. Afterwards, 
OSCSCs were removed, and the surface expressions of B7H1, CD54, MHC-1, and CD44 on untreated OSCSCs and those treated with NK cells were assessed 
after staining with the PE-conjugated antibodies and analyzed using flow cytometry. Isotype control antibodies were used as controls. The numbers on the right 
hand corner are the percentages and the mean channel fluorescence intensities for each histogram (F).
FigUre 4 | continued
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IL-10 appears to be important for the controlled differentiation 
of the cells, allowing for survivial.
DiscUssiOn
Previous studies have attributed significant health enhancing 
effect to probiotic bacteria; however, the underlying mechanisms 
for their effect on NK cells have not been elucidated yet. Here, 
we demonstrate that probiotic bacteria significantly induce split 
anergy in NK cells, resulting in substantial secretion of cytokines 
important in the differentiation of cells and cessation of inflam-
mation. Probiotic bacteria induced significant levels of pro- and 
anti-inflammatory cytokines, chemokines, and growth factors 
by NK cells in the absence of other activating signals (Table S1 
in Supplementary Material). Interestingly, the addition of pro-
biotic bacteria in the presence of IL-2 or IL-2 + anti-CD16mAb 
decreased release of the majority of pro- and anti-inflammatory 
cytokines, chemokines, and growth factors, with the exception of 
a few, most notably IFN-γ and IL-1Ra which were significantly 
upregulated. These data indicate the potential balancing effect of 
bacteria on NK cell activation. On the one hand, probiotic bacte-
ria stimulate NK cells to produce very high secretion of cytokines 
and chemokines in the absence of other NK cell activators, but on 
the other hand, they dampen secretion by NK cells when added 
to those activated with IL-2 or IL-2  +  anti-CD16mAb. Such 
potential balancing effect of the bacteria may be important to 
retain activation signals at a level that do not result in extremely 
high or low signaling in NK cells in order to prevent over or under 
activation of NK cells, respectively. This may likely be one reason 
why increased cell death in NK cells was not observed above and 
beyond that which was seen by IL-2 + anti-CD16mAb-treated 
NK cells in which we had previously reported activation-induced 
cell death. Indeed, when bacteria were added to IL-2 +  anti-
CD16mAb-treated NK cells, 55-fold increase in IFN-γ secretion 
could be seen by certain bacterial species when compared to the 
same treatment without the addition of the bacteria (Table S1 in 
Supplementary Material).
Unique cell profiles, in respect to the extent of sensitivity to 
NK cell-mediated cytotoxicity, cell growth, and viability, were 
observed when OSCSCs, MP2, and SCAPs were treated with 
either supernatant or fixed IL-2 + anti-CD16mAb + sAJ2-treated 
NK cells (Figures 2 and 3; Figures S2 and S5 in Supplementary 
Material). Furthermore, different amounts of NK supernatants 
containing IFN-γ were required for the complete differentiation 
of each of the three cell types. When NK cells were stimulated with 
IL-2 + anti-CD16mAb and bacteria in the presence of monocytes, 
which induce IFN-γ and TNF-α at a much higher level than those 
cultured without monocytes, a substantial increase in the resist-
ance to NK cell-mediated cytotoxicity as well as some increase in 
cell death of differentiated stem cells could be observed, although 
the levels differed depending on stem cell type (Figure 4). These 
results indicated that each stem cell type has a different thresh-
old for undergoing cell death after differentiation even though 
they all become resistant to NK cell-mediated cytotoxicity, and 
this is likely due to the expression levels of IFN-γ and TNF-α 
receptors after differentiation (4, 24, 25). In this regard, we have 
found OSCSCs to have higher cell death after differentiation 
with relatively lower amounts of supernatants, whereas MP2 was 
resistant at higher levels of NK supernatant treatment and did not 
undergo cell death (4, 24, 25). The observed differences could be 
the reason why specific tumors are more effectively controlled 
than others, providing the rationale for designing effective treat-
ment strategies.
Differentiation of OSCSCs and MP2 stem-like tumors by 
IL-2 + anti-CD16mAb + sAJ2-treated NK cells inhibited greatly 
the secretion of cytokines and chemokines when they were 
cultured with freshly isolated IL-2-activated NK cells. Addition 
of anti-IFN-γ antibody but not anti-TNF-α antibody was able 
to reverse the inhibition of IFN-γ and IL-8 secretion resulting 
in the restoration of their secretion. This observation is of great 
FigUre 5 | il-10 regulation of nK cell mediated csc differentiation in the presence of saJ2 and monocytes is much more pronounced in untreated 
nK cells when compared to those treated with il-2 and anti-cD16mab. Highly purified NK cells were left untreated or treated with IL-2 (1,000 U/mL) and 
anti-CD16mAb (3 μg/mL) with sAJ2 at 1:3 (NK:sAJ2) ratio, monocytes at 1:1 (NK:monocyte) ratio, and/or anti-IL-10 (10 μg/mL) for 18 h. Afterwards, supernatants 
were harvested and added to OSCSCs for a period of 3 days. Then, untreated OSCSCs and those treated with NK cell supernatants were detached from the tissue 
culture plates, washed with 1× PBS and labeled with 51Cr. Freshly isolated NK cells were left untreated or treated with IL-2 (1,000 U/mL) for 24 h before the cells 
were used as effector cells in 51Cr release assay against OSCSCs. The lytic units 30/106 cells were determined using inverse number of NK cells required to lyse 30% 
of the target cells ×100 (a). NK cells were prepared as described in (a), and after an overnight incubation period, the supernatants were harvested, and the levels of 
IFN-γ secretions were determined using specific ELISAs. Differences between untreated NK cells and those cultured with monocytes and sAJ2 were significant at a 
P-value of <0.05 (*) (B). Untreated NK cells were cultured with autologous monocytes at 1:1 (NK:monocyte) ratio in the presence or absence of anti-IL-10 (10 μg/mL) 
and/or sAJ2 at 1:3 (NK:sAJ2) ratio for 18 h. Anti-IL-10 (10 μg/mL) was added to untreated NK cells and monocytes and used as controls. 
(Continued)
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FigUre 5 | continued 
After an overnight treatment period, the supernatants were removed and added to OSCSCs for 3 days (c). NK cells supernatants were prepared as described in  
(a) and added to OSCSCs for 3 days (D). Afterwards, untreated and treated OSCSCs were detached from the tissue culture plate and washed with 1× PBS. The 
surface expression of B7H1, CD54, MHC-1, and CD44 was assessed after staining with the PE-conjugated antibodies and analyzed using flow cytometry. Isotype 
control antibodies were used as controls. The numbers on the right-hand corner are the percentages, and the mean channel fluorescence intensities for each 
histogram (c) and (D). OSCSCs were differentiated with NK cell supernatants as described in (D), and at the end of the treatment period, the viability of OSCSCs 
was assessed with propidium iodide staining followed by flow cytometric analysis (e). The numbers on the right hand corner are the percentages of dead cells in 
each histogram.
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significance since it indicates that cellular differentiation is an 
important step in the prevention of inflammation. Indeed, IFN-γ 
secreted by the activated NK cells limits its own production when 
the stem cells are differentiated which establishes a loop in which 
the higher the levels of IFN-γ secreted from NK cells the more 
inhibition of inflammation can be seen. Therefore, any suppres-
sion in NK cell-mediated secretion of IFN-γ may cause chronicity 
of inflammation.
Certain Lactobacillus species and S. thermophiles in contrast 
to bifidobacteria induce a Th1-type cytokine profile, i.e., increase 
in IL-12 and IFN-γ and decrease in IL-10 cytokines whereas 
bifidobacteria triggers relatively more of IL-10 and IL-6 and less 
of IL-12 and IFN-γ from NK cells which is a Th2-type profile 
(Table S1 in Supplementary Material). The role of IL-10 in the 
regulation of IFN-γ secretion has clearly been shown in a number 
of previous studies; however, its role in the differentiation of the 
cells has not been shown or proposed previously. In this paper, 
we demonstrate the significance of IL-10 in regulating NK cell-
induced differentiation of the tumor cells. It is clear that NK cells 
exhibit very low secretion of IL-10 in the absence of bacteria, but 
when activated with probiotic bacteria they induce significant 
levels of IL-10, and the amounts synergistically increase in the 
presence of monocytes. Activation of NK cells with IL-2 or 
IL-2 +  anti-CD16mAb decreases secretion of bacteria induced 
IL-10, indicating the cross regulation of IFN-γ and IL-10. 
Addition of anti-IL-10mAb increases IFN-γ significantly when 
added to the cultures of probiotic bacteria-treated NK cells 
with monocytes in the absence of NK activation with IL-2 or 
IL-2 + anti-CD16mAb, which results in substantial increases in 
B7H1, CD54, and MHC-I surface expression, whereas those that 
are activated with IL-2 or IL-2 + anti-CD16mAb in the presence 
of probiotic bacteria only moderately increase surface expression 
of the above-mentioned receptors in the presence and absence 
of monocytes after treatment with anti-IL-10mAb. Since IL-2 
or IL-2 +  anti-CD16mAb inhibits IL-10 secretion triggered by 
bacteria, the lack of substantial increase in surface receptors when 
anti-IL-10mAb is added could be due to the limited induction 
of IL-10. Similarly, higher increase in tumor differentiation with 
anti-IL10mAb correlates with increased resistance of tumor cells 
to NK cell-mediated cytotoxicity which closely correlates to the 
increase in IFN-γ secretion. Therefore, IL-10 is an important 
regulator of differentiation of the cells and limits over differentia-
tion of the cells which may result in their cell death. Addition of 
IL-10 to NK cells inhibited IFN-γ secretion (data not shown).
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